Available in three anodised colours, the E26-UV Kunai doesn’t just shine a light; it also features a UV (ultraviolet) ...

The electronics of the future can be made even smaller and more efficient by getting more memory cells to fit in less space.

She is also a Certified Stress Management Coach. Do blue light glasses actually work? Though they claim to reduce eyestrain and headaches and help you sleep better, no robust research confirms ...

If you’re pressed for time, here’s a quick look at our top five: Also known as wake up light alarms, bodyclock lights, natural light alarm clocks or SAD alarm clocks, these devices provide a ...

Share on Pinterest Scientists are investigating xenon gas as a potential treatment for Alzheimer’s. Westend61/Getty Images Researchers continue to search for effective treatments for Alzheimer ...

Recently, the Financial Times released an article featuring a climbing company whose goal is to offer their clients the use of xenon gas to make acclimatizing safer and to cut down the length of ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.

The study found that Xenon gas inhalation suppressed neuroinflammation, reduced brain atrophy, and increased protective neuronal states in mouse models of Alzheimer's disease. Results are ...

The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its molecular structure, don’t typically interact with many chemicals.

New research from Mass General Brigham and Washington University School of Medicine in St. Louis found Xenon gas inhalation reduced neurodegeneration and boosted protection in preclinical models o ...

There’s no better example of having a case of Mondays than the day after the Super Bowl. Coors Light announced Wednesday that it’s temporarily changing its name to “Mondays Light” in an ...

Xenon Pharmaceuticals (XENE) outlined progress within its pipeline programs and key milestones for 2025. Phase 3 azetukalner clinical studies in focal onset seizures continue to advance, with the ...